Walter Verbeek

2.5k total citations
55 papers, 1.5k citations indexed

About

Walter Verbeek is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Walter Verbeek has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 19 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Walter Verbeek's work include Acute Myeloid Leukemia Research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Walter Verbeek is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Walter Verbeek collaborates with scholars based in Germany, United States and Netherlands. Walter Verbeek's co-authors include W. SUNDERMEYER, H. Phillip Koeffler, Carsten Müller‐Tidow, Adrian F. Gombart, Arnold Ganser, C. Kik, Bernhard Wörmann, J.W. van Ooijen, W. A. Wietsma and A.W. van Heusden and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Walter Verbeek

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter Verbeek Germany 23 583 569 247 230 225 55 1.5k
W. L. Bigbee United States 17 159 0.3× 1.1k 2.0× 258 1.0× 197 0.9× 35 0.2× 33 1.6k
Gary S. David United States 16 175 0.3× 772 1.4× 227 0.9× 230 1.0× 80 0.4× 41 1.7k
Hitomi Yamamoto Japan 20 226 0.4× 675 1.2× 542 2.2× 506 2.2× 77 0.3× 40 1.7k
Kathleen N. S. Cathcart United States 14 287 0.5× 327 0.6× 211 0.9× 340 1.5× 162 0.7× 16 1.1k
Gianmarco Corneo Italy 18 287 0.5× 983 1.7× 26 0.1× 198 0.9× 170 0.8× 34 1.4k
Emadoldin Feyzi Norway 11 102 0.2× 987 1.7× 107 0.4× 191 0.8× 69 0.3× 11 1.3k
Anlai Wang United States 12 312 0.5× 330 0.6× 356 1.4× 228 1.0× 103 0.5× 40 958
R. J. Flemans United Kingdom 14 332 0.6× 406 0.7× 143 0.6× 44 0.2× 156 0.7× 23 1.0k
Bin Zhou China 22 117 0.2× 1.0k 1.8× 115 0.5× 148 0.6× 88 0.4× 72 1.5k
Gary M. Kupfer United States 31 136 0.2× 2.3k 4.1× 266 1.1× 704 3.1× 56 0.2× 74 2.9k

Countries citing papers authored by Walter Verbeek

Since Specialization
Citations

This map shows the geographic impact of Walter Verbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Verbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Verbeek more than expected).

Fields of papers citing papers by Walter Verbeek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Verbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Verbeek. The network helps show where Walter Verbeek may publish in the future.

Co-authorship network of co-authors of Walter Verbeek

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Verbeek. A scholar is included among the top collaborators of Walter Verbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Verbeek. Walter Verbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlenk, Richard F., Frank Stegelmann, Andreas Reiter, et al.. (2016). Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis. Leukemia. 31(4). 889–895. 14 indexed citations
2.
Schönberg, Kathrin, Janna Rudolph, Sowmya Parampalli Yajnanarayana, et al.. (2015). JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms. Cancer Research. 75(11). 2187–2199. 123 indexed citations
3.
Agrawal, Shuchi, Matthias Unterberg, Steffen Koschmieder, et al.. (2007). DNA Methylation of Tumor Suppressor Genes in Clinical Remission Predicts the Relapse Risk in Acute Myeloid Leukemia. Cancer Research. 67(3). 1370–1377. 81 indexed citations
4.
Verbeek, Walter & Ullrich Graeven. (2005). Welche Rolle spielen die neuen Therapieoptionen in der palliativen Therapie des Kolonkarzinoms?. Der Internist. 46(12). 1339–1346.
5.
Verbeek, Walter, et al.. (2004). Endoskopische Spaltung eines intraluminalen Duodenaldivertikels beim Erwachsenen wegen Oberbauchbeschwerden. Zeitschrift für Gastroenterologie. 42(12). 1377–1379. 1 indexed citations
7.
Tiesmeier, Jens, Andreas Czwalinna, Carsten Müller‐Tidow, et al.. (2003). Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia. British Journal of Haematology. 123(3). 413–419. 35 indexed citations
8.
Krug, Utz, Jens Tiesmeier, Manuel Aivado, et al.. (2003). The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML. Leukemia. 17(2). 343–349. 33 indexed citations
9.
Ganser, Arnold, et al.. (2002). In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF). Annals of Hematology. 81(12). 695–700. 5 indexed citations
10.
Verbeek, Walter, et al.. (2001). C/EBPε −/− mice: increased rate of myeloid proliferation and apoptosis. Leukemia. 15(1). 103–111. 20 indexed citations
11.
Verbeek, Walter, et al.. (2000). Measurement of thrombopoietic levels: clinical and biological relationships. Current Opinion in Hematology. 7(3). 143–149. 11 indexed citations
12.
Hiddemann, Wolfgang, et al.. (1998). Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities. Leukemia Research. 22. S23–S26. 7 indexed citations
13.
Verbeek, Walter, Matthew Frankel, Steven A. Miles, Jonathan Said, & H. Phillip Koeffler. (1998). Seroprevalence of HHV-8 Antibodies in HIV-Positive Homosexual Men Without Kaposi’s Sarcoma and Their Clinical Follow-Up. American Journal of Clinical Pathology. 109(6). 778–783. 18 indexed citations
14.
Verbeek, Walter, Adrian F. Gombart, Masaaki Shiohara, Moray J. Campbell, & H. Phillip Koeffler. (1997). Vitamin D Receptor: No Evidence for Allele-Specific mRNA Stability in Cells Which Are Heterozygous for the Taq I Restriction Enzyme Polymorphism. Biochemical and Biophysical Research Communications. 238(1). 77–80. 84 indexed citations
15.
Verbeek, Walter, Bernhard Wörmann, P. Koch, et al.. (1997). S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes. Annals of Hematology. 74(5). 205–208. 16 indexed citations
16.
Verbeek, Walter, Andreas Humpe, C. Troff, et al.. (1995). Mobilization of CD34‐positive tumour cells in a patient with testicular mixed germ cell tumour. British Journal of Haematology. 90(4). 947–950. 5 indexed citations
17.
Verbeek, Walter, et al.. (1995). The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 121(6). 338–342. 3 indexed citations
18.
Hakkert, Johanna C., et al.. (1992). Genome composition of asymmetric hybrids in relation to the phylogenetic distance between the parents. Nucleus-chloroplast interaction. Theoretical and Applied Genetics. 84-84(7-8). 930–940. 31 indexed citations
19.
Verbeek, Walter & W. SUNDERMEYER. (1967). Preparation of Carbonyl and Fluorocarbonyl Pseudohalides in Molten Salts. Angewandte Chemie International Edition in English. 6(10). 871–872. 24 indexed citations
20.
Verbeek, Walter & W. SUNDERMEYER. (1967). Darstellung von Carbonyl‐ und Fluorcarbonyl‐pseudohalogeniden in der Salzschmelze. Angewandte Chemie. 79(19). 860–861. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026